News
Abbott (ABT) has announced new data from its Volt CE Mark Study that show strong safety and efficacy out to 12 months for patients receiving ...
Abbott (NYSE: ABT) has announced new data from its Volt CE Mark Study that show strong safety and efficacy out to 12 months ...
3d
Creative Bloq on MSNWhy does the Apple logo have a bite mark?Apple's logo is one of the most iconic out there – but there's confusion over why exactly the fruit has a bite taken out of ...
4d
CarBuzz on MSNFord's New Trademark Hints At The Revival Of Shelby's IconI s Ford taking a page from Jaguar with its latest trademark filing? Ford has just applied for a trademark in Europe for ...
The Aviator trend is a stylish trend that has been hugely popular for many years.Jake revealed that retro styles are popular, ...
In a dramatic unveiling, musician Justin Bieber has cut ties with his old clothing brand, Drew House, to begin a brand new ...
Novocure (NVCR) announced that Optune Lua has received a CE Mark for the treatment of adult patients with metastatic non-small cell lung cancer ...
Edwards Lifesciences Corporation today announced the company's SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic ...
WASHINGTON (AP) — Meta CEO Mark Zuckerberg took to the witness stand on the first day of a historic antitrust trial to defend his company against allegations it illegally monopolized the social media ...
Image credit: Shutterstock/Steve Cukrov. Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up market rivalry with Abbott. Edwards ...
"Prof. Valmed" was the first company to receive approval from the European Union for its co-pilot of the same name.
voxel-based dosimetry platform for SIRT and MRT – now approved for market in EU under CE MDR Mark and in the US with FDA 510(k) clearance . End-to-end, versatile, vendor-neutral, the novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results